US Stock MarketDetailed Quotes

Anebulo Pharmaceuticals (ANEB)

Watchlist
  • 0.4800
  • +0.0407+9.25%
15min DelayClose Apr 24 15:23 ET
19.57MMarket Cap-2.67P/E (TTM)

Anebulo Pharmaceuticals (ANEB) Balance Sheet

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Dec 31, 2025
(Q1)Sep 30, 2025
(FY)Jun 30, 2025
(Q4)Jun 30, 2025
(Q3)Mar 31, 2025
(Q2)Dec 31, 2024
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments
-39.72%9.04M
637.41%10.35M
275.80%11.63M
275.80%11.63M
158.01%13.28M
125.73%15M
-83.52%1.4M
-72.49%3.09M
-72.49%3.09M
-63.66%5.15M
-Cash and cash equivalents
-39.72%9.04M
637.41%10.35M
275.80%11.63M
275.80%11.63M
158.01%13.28M
125.73%15M
-83.52%1.4M
-72.49%3.09M
-72.49%3.09M
-63.66%5.15M
Receivables
84.62%56.78K
-96.00%9.83K
--73.22K
--73.22K
----
--30.76K
--245.36K
--0
--0
----
-Other receivables
84.62%56.78K
-96.00%9.83K
--73.22K
--73.22K
----
--30.76K
--245.36K
----
----
----
Prepaid assets
-52.11%175.41K
-45.43%170.77K
-36.82%261.44K
-36.82%261.44K
136.07%528.03K
113.27%366.27K
-40.65%312.94K
-2.12%413.79K
-2.12%413.79K
-16.48%223.68K
Total current assets
-39.76%9.27M
436.83%10.54M
241.01%11.96M
241.01%11.96M
157.09%13.81M
125.86%15.4M
-78.31%1.96M
-69.94%3.51M
-69.94%3.51M
-62.79%5.37M
Non current assets
Other non current assets
-66.74%148.23K
-67.22%165.67K
-67.60%183.11K
-67.60%183.11K
-67.90%200.55K
-34.88%445.73K
--505.43K
--565.12K
--565.12K
--624.82K
Total non current assets
-66.74%148.23K
-67.22%165.67K
-67.60%183.11K
-67.60%183.11K
-67.90%200.55K
-34.88%445.73K
--505.43K
--565.12K
--565.12K
--624.82K
Total assets
-40.52%9.42M
333.60%10.7M
198.19%12.15M
198.19%12.15M
133.64%14.01M
111.19%15.84M
-72.72%2.47M
-65.10%4.07M
-65.10%4.07M
-58.46%6M
Liabilities
Current liabilities
Payables
73.66%554.86K
140.95%607.54K
43.31%224.18K
43.31%224.18K
11.08%427.58K
0.26%319.52K
-55.45%252.14K
-70.74%156.43K
-70.74%156.43K
-32.58%384.92K
-accounts payable
73.66%554.86K
140.95%607.54K
43.31%224.18K
43.31%224.18K
11.08%427.58K
0.26%319.52K
-55.45%252.14K
-70.74%156.43K
-70.74%156.43K
-32.58%384.92K
Current accrued expenses
66.42%930.78K
12.36%356.28K
153.00%263.51K
153.00%263.51K
-81.06%118.45K
-19.51%559.28K
110.53%317.08K
-80.50%104.16K
-80.50%104.16K
-32.04%625.4K
Current liabilities
69.05%1.49M
69.32%963.82K
87.15%487.69K
87.15%487.69K
-45.95%546.03K
-13.30%878.8K
-20.56%569.23K
-75.62%260.58K
-75.62%260.58K
-32.24%1.01M
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
69.05%1.49M
69.32%963.82K
87.15%487.69K
87.15%487.69K
-45.95%546.03K
-13.30%878.8K
-20.56%569.23K
-75.62%260.58K
-75.62%260.58K
-32.24%1.01M
Shareholders'equity
Share capital
0.00%41.09K
58.43%41.09K
58.43%41.09K
58.43%41.09K
58.43%41.09K
58.43%41.09K
1.17%25.93K
1.17%25.93K
1.17%25.93K
1.17%25.93K
-common stock
0.00%41.09K
58.43%41.09K
58.43%41.09K
58.43%41.09K
58.43%41.09K
58.43%41.09K
1.17%25.93K
1.17%25.93K
1.17%25.93K
1.17%25.93K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-11.39%-78.05M
-12.49%-76.05M
-12.97%-73.89M
-12.97%-73.89M
-12.01%-71.74M
-12.29%-70.07M
-13.27%-67.6M
-14.34%-65.4M
-14.34%-65.4M
-17.09%-64.05M
Paid-in capital
1.12%85.94M
23.41%85.74M
23.58%85.51M
23.58%85.51M
23.40%85.17M
23.42%84.99M
2.19%69.48M
2.08%69.19M
2.08%69.19M
2.06%69.01M
Total stockholders'equity
-46.96%7.94M
412.83%9.74M
205.78%11.66M
205.78%11.66M
170.04%13.46M
130.64%14.96M
-77.21%1.9M
-64.04%3.81M
-64.04%3.81M
-61.48%4.99M
Total equity
-46.96%7.94M
412.83%9.74M
205.78%11.66M
205.78%11.66M
170.04%13.46M
130.64%14.96M
-77.21%1.9M
-64.04%3.81M
-64.04%3.81M
-61.48%4.99M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Dec 31, 2025(Q1)Sep 30, 2025(FY)Jun 30, 2025(Q4)Jun 30, 2025(Q3)Mar 31, 2025(Q2)Dec 31, 2024(Q1)Sep 30, 2024(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments -39.72%9.04M637.41%10.35M275.80%11.63M275.80%11.63M158.01%13.28M125.73%15M-83.52%1.4M-72.49%3.09M-72.49%3.09M-63.66%5.15M
-Cash and cash equivalents -39.72%9.04M637.41%10.35M275.80%11.63M275.80%11.63M158.01%13.28M125.73%15M-83.52%1.4M-72.49%3.09M-72.49%3.09M-63.66%5.15M
Receivables 84.62%56.78K-96.00%9.83K--73.22K--73.22K------30.76K--245.36K--0--0----
-Other receivables 84.62%56.78K-96.00%9.83K--73.22K--73.22K------30.76K--245.36K------------
Prepaid assets -52.11%175.41K-45.43%170.77K-36.82%261.44K-36.82%261.44K136.07%528.03K113.27%366.27K-40.65%312.94K-2.12%413.79K-2.12%413.79K-16.48%223.68K
Total current assets -39.76%9.27M436.83%10.54M241.01%11.96M241.01%11.96M157.09%13.81M125.86%15.4M-78.31%1.96M-69.94%3.51M-69.94%3.51M-62.79%5.37M
Non current assets
Other non current assets -66.74%148.23K-67.22%165.67K-67.60%183.11K-67.60%183.11K-67.90%200.55K-34.88%445.73K--505.43K--565.12K--565.12K--624.82K
Total non current assets -66.74%148.23K-67.22%165.67K-67.60%183.11K-67.60%183.11K-67.90%200.55K-34.88%445.73K--505.43K--565.12K--565.12K--624.82K
Total assets -40.52%9.42M333.60%10.7M198.19%12.15M198.19%12.15M133.64%14.01M111.19%15.84M-72.72%2.47M-65.10%4.07M-65.10%4.07M-58.46%6M
Liabilities
Current liabilities
Payables 73.66%554.86K140.95%607.54K43.31%224.18K43.31%224.18K11.08%427.58K0.26%319.52K-55.45%252.14K-70.74%156.43K-70.74%156.43K-32.58%384.92K
-accounts payable 73.66%554.86K140.95%607.54K43.31%224.18K43.31%224.18K11.08%427.58K0.26%319.52K-55.45%252.14K-70.74%156.43K-70.74%156.43K-32.58%384.92K
Current accrued expenses 66.42%930.78K12.36%356.28K153.00%263.51K153.00%263.51K-81.06%118.45K-19.51%559.28K110.53%317.08K-80.50%104.16K-80.50%104.16K-32.04%625.4K
Current liabilities 69.05%1.49M69.32%963.82K87.15%487.69K87.15%487.69K-45.95%546.03K-13.30%878.8K-20.56%569.23K-75.62%260.58K-75.62%260.58K-32.24%1.01M
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities 69.05%1.49M69.32%963.82K87.15%487.69K87.15%487.69K-45.95%546.03K-13.30%878.8K-20.56%569.23K-75.62%260.58K-75.62%260.58K-32.24%1.01M
Shareholders'equity
Share capital 0.00%41.09K58.43%41.09K58.43%41.09K58.43%41.09K58.43%41.09K58.43%41.09K1.17%25.93K1.17%25.93K1.17%25.93K1.17%25.93K
-common stock 0.00%41.09K58.43%41.09K58.43%41.09K58.43%41.09K58.43%41.09K58.43%41.09K1.17%25.93K1.17%25.93K1.17%25.93K1.17%25.93K
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -11.39%-78.05M-12.49%-76.05M-12.97%-73.89M-12.97%-73.89M-12.01%-71.74M-12.29%-70.07M-13.27%-67.6M-14.34%-65.4M-14.34%-65.4M-17.09%-64.05M
Paid-in capital 1.12%85.94M23.41%85.74M23.58%85.51M23.58%85.51M23.40%85.17M23.42%84.99M2.19%69.48M2.08%69.19M2.08%69.19M2.06%69.01M
Total stockholders'equity -46.96%7.94M412.83%9.74M205.78%11.66M205.78%11.66M170.04%13.46M130.64%14.96M-77.21%1.9M-64.04%3.81M-64.04%3.81M-61.48%4.99M
Total equity -46.96%7.94M412.83%9.74M205.78%11.66M205.78%11.66M170.04%13.46M130.64%14.96M-77.21%1.9M-64.04%3.81M-64.04%3.81M-61.48%4.99M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More